Zeng, Lansheng – Trademark Portfolio
Entity Type: 01
Zeng, Lansheng owns a portfolio of 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as QRFWTX, SDFQWG, ETGRDHA, GATASCK, and IRTYQWE. Of these, 15 are registered. The portfolio spans 5 Nice Classification classes, led by Class 9 (Computers & Electronics) and Class 5 (Pharmaceuticals). Headquartered in Ganzhou, Jiangxi.
No. 8, Kengkou group, huangshakeng vil.,
wuzhifeng Township, Shangyou County,
Ganzhou, Jiangxi 341200 , CN
Showing of trademarks Trademarks
Trademark Classifications
Zeng, Lansheng's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Lace and embroidery, ribbons and braid; buttons, hooks and eyes, pins and needles
Frequently Asked Questions
How many trademarks does Zeng, Lansheng have?
Zeng, Lansheng has 15 U.S. trademarks filed with the USPTO. Of these, 15 registered.
What trademark classes does Zeng, Lansheng file in?
Zeng, Lansheng files trademarks across 5 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 5 (Pharmaceuticals), Class 25 (Clothing), Class 20 (Furniture), Class 26 (Fancy Goods). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Zeng, Lansheng's most well-known trademarks?
Zeng, Lansheng's registered trademark portfolio includes well-known marks such as QRFWTX, SDFQWG, ETGRDHA, GATASCK, and IRTYQWE. These are among 15 currently registered trademarks in the portfolio.
What is Zeng, Lansheng's trademark registration success rate?
Zeng, Lansheng has a 100% trademark registration rate, with 15 out of 15 resolved applications resulting in successful registration. Currently, 0 applications are pending review.